Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Using a simple decision rule and a finger prick to test blood, general practitioners could substantially reduce the number of ill children being referred to hospital, if the test is used on children identified as ‘at-risk’ of a serious infection.

A simple finger prick test could substantially reduce the number of ill children being referred to hospital. © Shutterstock
A simple finger prick test could substantially reduce the number of ill children being referred to hospital.
Our study showed that with this procedure, all serious infections were detected during the first visit to the general practitioner.
- Dr Jan Verbakel, University of Oxford.

The researchers from Belgium and Oxford, led by Dr Jan Verbakel, an Honorary Clinical Lecturer in Oxford University’s Nuffield Department of Primary Care Health Sciences, claim that their findings are important for improving the accuracy of diagnosis of unwell children in primary care, which could reduce the number of unnecessary hospital referrals, and ultimately, the strain on secondary health care services.

The research is published in BMC Medicine.

In the early stages, serious infections such as meningitis, pneumonia, kidney or bone infections, or dangerous inflammations of the skin have symptoms that resemble those of more common viral infections. They are also very rare. “As a result, serious infections tend to stay off the general practitioner’s radar for too long. We asked ourselves how rapid diagnostic tests might help solve this problem,” says Jan Verbakel, who is also a Belgium-based GP and a postdoctoral researcher at KU Leuven Faculty of Medicine, where the clinical study was carried out.

The rapid point-of-care blood test for the inflammatory marker C-reactive protein (CRP) takes only 4 minutes and, in this study, was able to rule out serious infection in nearly 40% of children who presented as being at-risk by the usual clinical assessment. This includes at least one of the symptoms: breathlessness, a temperature of 40°C and above, or diarrhoea if the child is aged between 12-30 months.

In their randomised trial involving 78 General Practices and 3,100 unwell children across Flanders in Belgium, the researchers showed that the usual clinical assessment would flag 57 children for referral to hospital, out of which only 1 would be found to have a serious infection. Including the CRP test in these cases could reduce the number of referrals to 35.

“Point-of-care CRP testing cannot replace a general practitioner. Does the GP sense that something is off? Is the child short of breath, or running a fever of more than 40°C? If the answer to any of these questions is yes, it’s useful to perform a point-of-care CRP test. Our study showed that with this procedure, all serious infections were detected during the first visit to the general practitioner. But there’s no need to test all ill children.”

“Thanks to the combination of a clinical examination of the patient, possibly followed by a point-of-care CRP test, general practitioners can detect serious infections more quickly and more objectively. And for children who are less seriously ill, the procedure prevents unnecessary hospital referrals and anxiety. The point-of-care CRP test is a valuable tool for general practitioners, but it has to be used responsibly,” Verbakel concludes.

 

Should all acutely ill children in primary care be tested with point-of-care CRP: A cluster randomised trial.
Verbakel JY, Lemiengre MB, Burghgraeve TD, De Sutter A, Aertgeerts B, Shinkins B, Perera R, Mant D, Van den Bruel A, Buntinx F.
BMC Medicine 2016 14:131 DOI: 10.1186/s12916-016-0679-2 

Researcher profiles:

Similar stories

Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial

COVID-19 Clinical trials Infection & acute care

In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.

Oxford to trial new COVID-19 test for individuals without symptoms

COVID-19 Infection & acute care

Led by a research team in the Nuffield Department of Primary Care Health Sciences, the University of Oxford will take part in a new pilot scheme to assess the use of Lateral Flow Tests (LFTs), a new COVID-19 test designed to identify asymptomatic individuals with the virus.

RCGP Research Paper of the Year awarded to study led by Professor Chris Butler

Awards & appointments Clinical trials Infection & acute care

The importance of patient and public contributors is recognised as key to the success of the study.

Britain’s most influential Hindu temple spreads awareness of the PRINCIPLE trial among Indian community

COVID-19 Clinical trials Infection & acute care

Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.

New risk model estimates likelihood of hospitalisation or death from COVID-19

Big data COVID-19 Infection & acute care

A new risk model, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from Covid-19 has been published by The BMJ

PRINCIPLE Trial of COVID-19 treatments recruits 1000th participant

COVID-19 Clinical trials Infection & acute care

More than 1000 people across the UK have signed-up to take part in the UK-wide PRINCIPLE Trial of potential community-based treatments for COVID-19, led by Oxford University.